CytoSorbents appoints Peter J. Mariani as CFO; Kathleen P. Bloch retires

Cytosorbents Corp

Peter J. Mariani appointed CFO effective Aug 14, 2024; previously CFO of Axogen (2016-2023).
Mariani receives base salary of $425,000, cash bonus up to 45%, and inducement awards of stock options & RSUs.
Kathleen P. Bloch retired as CFO and will serve as consultant at $335/hour through Dec 31, 2025.
CEO highlights Mariani's experience as company pursues U.S. FDA/Health Canada approval for DrugSorb-ATR.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Kathleen P. Bloch

Chief Financial Officer

CTSO · Cytosorbents Corp

Effective: 2024-08-14
Successor: Peter J. Mariani
Filed: August 16, 2024, 7:59 PM ET

the Company also announced the retirement of Ms. Kathleen P. Bloch, the Company’s then serving Chief Financial Officer, and her transition into a consulting role with the Company.

Appointed

Peter J. Mariani

Chief Financial Officer

CTSO · Cytosorbents Corp

Effective: 2024-08-14
Filed: August 16, 2024, 7:59 PM ET

On August 13, 2024, CytoSorbents Corporation (the “Company”) issued a press release announcing the appointment of Peter J. Mariani as the Company’s new Chief Financial Officer, effective as of August 14, 2024

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Kathleen P. Bloch retired as Chief Financial Officer at Cytosorbents Corp.

Action: retired
Role: Chief Financial Officer

Exact text from the filing

the Company also announced the retirement of Ms. Kathleen P. Bloch, the Company’s then serving Chief Financial Officer, and her transition into a consulting role with the Company.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Peter J. Mariani was appointed as Chief Financial Officer at Cytosorbents Corp.

Action: appointed
Role: Chief Financial Officer

Exact text from the filing

On August 13, 2024, CytoSorbents Corporation (the “Company”) issued a press release announcing the appointment of Peter J. Mariani as the Company’s new Chief Financial Officer, effective as of August 14, 2024

View on SEC.gov

Cytosorbents Corp filing history →

Source: SEC EDGAR

accession 0001104659-24-090567

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.